← Back to Search

Peer-Based Education for Prostate Cancer Screening

N/A
Waitlist Available
Research Sponsored by Thomas Jefferson University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline up to 2 months
Awards & highlights

Study Summary

This trial is studying how well a peer-based health education program works in reducing barriers to prostate cancer genetic screening in African American participants.

Who is the study for?
This trial is for African American individuals who are comfortable reading and speaking English, with or without a personal or family history of prostate cancer. It's open to anyone regardless of being a patient at CityLife Neighborhood Clinic. Men who were in a focus group can't join.Check my eligibility
What is being tested?
The study is testing if a peer-based health education program can help change attitudes and beliefs about genetic screening for prostate cancer. Participants will receive educational materials and complete questionnaires as part of the intervention.See study design
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, there are no direct physical side effects expected from participating.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline up to 2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline up to 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Awareness of risks and benefits of genetic testing
Change in of decisional conflict
Genetic testing
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (health education)Experimental Treatment2 Interventions
Participants attend 1-2 monthly peer educator-led education sessions about PCA genetic testing over 3 hours each for 18 months.
Group II: Arm II (cancer educational materials)Active Control2 Interventions
Participants receive mailed informational materials about PCA risk, family history, and genetic testing.

Find a Location

Who is running the clinical trial?

United States Department of DefenseFED
861 Previous Clinical Trials
227,045 Total Patients Enrolled
Thomas Jefferson UniversityLead Sponsor
444 Previous Clinical Trials
145,475 Total Patients Enrolled

Media Library

Educational Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05011799 — N/A
Healthy Subjects Research Study Groups: Arm I (health education), Arm II (cancer educational materials)
Healthy Subjects Clinical Trial 2023: Educational Intervention Highlights & Side Effects. Trial Name: NCT05011799 — N/A
Educational Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05011799 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What qualifications are necessary for participants to be accepted into this research project?

"To qualify for this medical study, participants must demonstrate general health and fall within the acceptable age range of 35 to 69. Currently 176 people have been accepted as candidates."

Answered by AI

What is the scope of patient recruitment for this clinical trial?

"Affirmative. Clinicaltrials.gov provides evidence that this medical trial is actively recruiting for 176 subjects at 1 location, with the original post date being January 8th 2020 and the most recent update happening on August 14th 2023."

Answered by AI

Do adults aged 55 and over qualify for this trial?

"This particular study is reserved for those aged 35 to 69. For younger patients, there are 123 different trials available and 1715 more exist for seniors above the age of 65."

Answered by AI

Are there any available openings for participants in this research study?

"Correct. Per the information accessible on clinicaltrials.gov, this medical study is actively recruiting patients and opened for enrollment on January 8th 2020 with its most recent update being dated August 14th 2023. The trial currently has 176 participants enrolled at a single medical centre."

Answered by AI
~28 spots leftby Apr 2025